Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Total Current Assets
Prestige Consumer Healthcare Inc
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Total Current Assets
$393.8m
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Current Assets
$57B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
0%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Current Assets
$28.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Pfizer Inc
NYSE:PFE
|
Total Current Assets
$43.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-3%
|
|
Merck & Co Inc
NYSE:MRK
|
Total Current Assets
$31.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Current Assets
$25.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
See Also
What is Prestige Consumer Healthcare Inc's Total Current Assets?
Total Current Assets
393.8m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Total Current Assets amounts to 393.8m USD.
What is Prestige Consumer Healthcare Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
5%
Over the last year, the Total Current Assets growth was -4%. The average annual Total Current Assets growth rates for Prestige Consumer Healthcare Inc have been 9% over the past three years , 6% over the past five years , and 5% over the past ten years .